Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)
This study has been completed.
Study NCT00062582   Information provided by ALTANA Pharma
First Received: June 9, 2003   Last Updated: December 15, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
COPD
Additional conditions recognized in this trial
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiration Disorders
Signs and Symptoms, Respiratory
More general conditions related to this trial
Respiratory Tract Diseases
Signs and Symptoms
Interventions listed in this trial
Roflumilast
Sponsors listed in this trial
ALTANA Pharma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services